Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-04-30

FDA Approved: AMLODIPINE BESYLATE 2.5 MG — Supplemental Application (Oxford Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application to allow amlodipine besylate 2.5 mg as an additional dosage strength for Oxford Pharmaceuticals' product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate 2.5 mg (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE 2.5 MG (AMLODIPINE BESYLATE)